These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10779626)

  • 41. Thymidine and zidovudine metabolism in chronically zidovudine-exposed cells in vitro.
    Agarwal RP; Mian AM
    Biochem Pharmacol; 1991 Jul; 42(4):905-11. PubMed ID: 1867645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine.
    Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI
    J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of herpes simplex virus thymidine kinase to improve the antiviral activity of zidovudine.
    Guettari N; Loubière L; Brisson E; Klatzmann D
    Virology; 1997 Sep; 235(2):398-405. PubMed ID: 9281520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers.
    Olivero OA; Shearer GM; Chougnet CA; Kovacs AA; Baker R; Stek AM; Khoury MM; Poirier MC
    Ann N Y Acad Sci; 2000 Nov; 918():262-8. PubMed ID: 11131712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3'-Azido-3'-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria.
    Lynx MD; McKee EE
    Biochem Pharmacol; 2006 Jul; 72(2):239-43. PubMed ID: 16720018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
    Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
    Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.
    Marchand B; White KL; Ly JK; Margot NA; Wang R; McDermott M; Miller MD; Götte M
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2911-9. PubMed ID: 17517852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma and cellular markers of 3'-azido-3'-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs.
    Meng Q; Olivero OA; Fasco MJ; Bellisario R; Kaminsky L; Pass KA; Wade NA; Abrams EJ; Nesel CJ; Ness RB; Bigbee WL; O'Neill JP; Walker DM; Poirier MC; Walker VE
    Environ Mol Mutagen; 2007; 48(3-4):307-21. PubMed ID: 17358024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implication of the tRNA initiation step for human immunodeficiency virus type 1 reverse transcriptase in the mechanism of 3'-azido-3'-deoxythymidine (AZT) resistance.
    Vaccaro JA; Anderson KS
    Biochemistry; 1998 Oct; 37(40):14189-94. PubMed ID: 9760256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations.
    Torres SM; Walker DM; Carter MM; Cook DL; McCash CL; Cordova EM; Olivero OA; Poirier MC; Walker VE
    Environ Mol Mutagen; 2007; 48(3-4):224-38. PubMed ID: 17358033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats.
    Walker DM; Malarkey DE; Seilkop SK; Ruecker FA; Funk KA; Wolfe MJ; Treanor CP; Foley JF; Hahn FF; Hardisty JF; Walker VE
    Environ Mol Mutagen; 2007; 48(3-4):283-98. PubMed ID: 17358026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
    Chang S; Griesgraber GW; Southern PJ; Wagner CR
    J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zidovudine inhibits thymidine phosphorylation in the isolated perfused rat heart.
    Susan-Resiga D; Bentley AT; Lynx MD; LaClair DD; McKee EE
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1142-9. PubMed ID: 17220403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of granulocyte-macrophage colony-stimulating factor on 3'-azido-3'-deoxythymidine uptake, phosphorylation and nucleotide retention in human U-937 cells.
    Dhawan RK; Kharbanda S; Nakamura M; Ohno T; Kufe D
    Biochem Pharmacol; 1990 Dec; 40(12):2695-700. PubMed ID: 2260992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
    Olivero OA; Tejera AM; Fernandez JJ; Taylor BJ; Das S; Divi RL; Poirier MC
    Mutagenesis; 2005 Mar; 20(2):139-46. PubMed ID: 15784690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The M184V mutation reduces the selective excision of zidovudine 5'-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Apr; 76(7):3248-56. PubMed ID: 11884549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of mammalian DNA polymerase-associated 3' to 5' exonuclease activity by 5'-monophosphates of 3'-azido-3'-deoxythymidine and 3'-amino-3'-deoxythymidine.
    Bridges EG; Faraj A; Sommadossi JP
    Biochem Pharmacol; 1993 Apr; 45(8):1571-6. PubMed ID: 8387298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure of AZT: a molecular perspective.
    Hazuda D; Kuo L
    Nat Med; 1997 Aug; 3(8):836-7. PubMed ID: 9256270
    [No Abstract]   [Full Text] [Related]  

  • 60. Tenofovir (PMPA) is less susceptible to pyrophosphorolysis and nucleotide-dependent chain-terminator removal than zidovudine or stavudine.
    Naeger LK; Margot NA; Miller MD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):635-9. PubMed ID: 11563081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.